Bachelors degree required advanced degree preferred, scientific discipline preferred with at least 2 years of operational experience in pharmaceutical production, Supply Chain, Quality and/or clinical trials.
Trigger out of specification investigations upon detection of test results outside predefined specifications. Design and execute tests to confirm or rule out suspected root causes.
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL researchers.
Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other life-threatening illnesses, have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 diabetes (T2D) by converting pancreatic cells that normally produce insulin into those that increase blood sugar.
A new study has found that a simple kitchen ingredient — vinegar — can become a powerful germ killer when mixed with special microscopic particles. Scientists have discovered that this new combination could help fight dangerous bacteria that no longer respond to regular antibiotics.
Global pharmaceutical giant Eli Lilly and Company has announced plans to invest over USD 1 billion in India to expand its manufacturing capabilities and strengthen its presence in one of the world’s fastest-growing healthcare markets.
Wockhardt announced the submission of New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel antibacterial agent Zidebactam-Cefepime injection
M.Pharm in Pharmaceutical Sciences with first division from a recognized institute/university. 5-10 years of experience in pharmaceutical industry in formulation development and characterization.